International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 421-426
Original Article
Inflammatory Myofibroblastic Tumour of Ileo-Caecal Junction Presenting as Acute Intestinal Obstruction with Retrocolic Abscess in A Young Female- A Case Report
 ,
 ,
 ,
Received
Oct. 5, 2025
Accepted
Nov. 4, 2025
Published
Nov. 16, 2025
Abstract

Background: Inflammatory myofibroblastic tumour (IMT) is a very rare mesenchymal tumour with an unclear benign or malignant potential. Lung is the most common site of occurrence but less frequently it also occurs at various extra pulmonary sites. Common sites in abdomen include retroperitoneum and mesentery. Complete surgical excision is the standard of care and malignant variants need to be supported with adjuvant targeted therapy with ALK inhibitors.

Case report: We present here a case of IMT of ileo-caecal junction presenting as frank acute intestinal obstruction in an 18 year old female which highlights the potential of this tumour for causing life threatening emergencies. Patient underwent laparotomy with right hemicolectomy. Histopathology was consistent with IMT of ileocaecal junction with no atypia. Patient was kept on regular follow up and presently she is asymptomatic.

Conclusion: IMT is mainly a histopathological diagnosis and complete surgical excision with negative margins offers the best treatment. Owing to the risk of recurrence and malignant potential, regular follow up is mandatory and targeted therapy via ALK inhibitors is warranted in such situations

Keywords
INTRODUCTION

Inflammatory myofibroblastic tumour (IMT) is a very rare mesenchymal tumour with an unclear benign or malignant potential. It is mostly reported as of benign origin and its incidence is less than 1 % in the population.[1],[2] Common sites of its occurrence include lung, nose, throat, skin and extremities. Intraabdominal locations like omentum, mesentery and retroperitoneum have been reported in literature but overall incidence is extremely low.[3],[4],[5],[6]Clinical features of this condition are site specific and surgical excision is the most common treatment of choice. Intraabdominal IMT usually presents with abdominal pain, altered bowel habits, bleeding per rectum, intussusception and abdominal lump. We present here a case of IMT of ileo-caecal junction presenting as frank acute intestinal obstruction in a young female which highlights the potential of this tumour for causing life threatening emergencies.

 

Case presentation

An 18 year old female presented in surgical emergency with complains of pain in abdomen with distension and inability to pass flatus and feces for 5 days. She also had off and on low grade fever for 1 week and episodic vomiting. She had no history of similar complains in the past. Her menstrual history was within normal limits and she had no history of contact with any tuberculosis patient or anti tubercular drug intake.Her vitals at the time of presentation were: Blood pressure: 110/70 mmHg, Pulse rate: 100/ minute, respiratory rate: 18/ minute, temperature: afebrile. On examination her abdomen was distended and bowel sounds were absent. She also had tenderness in the right upper and right lower quadrant of abdomen. Patient had a contrast CT scan done from somewhere else which was also suggestive of multiple pockets of collection in the right paracolic gutter with maximum volume of 322 ml and non-visualisation of appendix and dilated small bowel loops. Based on these clinical and radiological findings, diagnosis of acute large bowel obstruction with suspected appendicular perforation was made. Patient was planned for surgical exploration.

 

On exploration small bowel loops were grossly dilated, a hard obstructing mass was present in the ileo-caecal junction with approximately 350 ml pus in the retrocolic region with grossly dilated small bowel loops. No obvious perforation was found at the tumour site but the appendix could not be identified during dissection which raised the possibility of sealed appendicular perforation. Right hemicolectomy with evacuation of pus and ileo-transverse anastomosis was done. Specimen was sent for histopathology. Postoperative outcome was uneventful and she was orally allowed on 7th day and abdominal drain was removed on 8th day. She was discharged on 9th day and was advised follow up with the histopathology report for further management. On follow up after a week she had no fresh complains and her histopathology was suggestive of inflammatory myofibroblastic tumour of ileo-caecal junction with no evidence of malignancy. Patient was kept under regular follow up every month for one year and presently she is asymptomatic. No adjuvant treatment either medical or radiation was given.

 

Figures

 

Figure 1a

 

Figure 1b

 

Figure 1c

 

Figure 1 a,b,c : CECT scan suggestive of multiple pockets of collection with air foci in right paracolic gutter with diffuse long segment thickening of ascending colon and caecum with obstructing lesion at ileo-caecal junction and dilated small bowel loops.

 

Figure 2 : Grossly dilated bowel loops with pus flakes

 

Figure 3: Right hemicolectomy specimen with a part of terminal ileum showing growth at the ileocaecal junction

 

Figure 4 a

 

Figure 4 b

 Figure 4 a,b : Sections from growth show diffuse areas of ulcerated mucosa and displaying panmural proliferation of myofibroblasts and fibroblastic spindle cells with intense mixed inflammatory cell infiltrate comprising of lymphocytes, plasma cells, histiocytes and polymorphs. These myofibroblasts are oval to spindle shaped, having bland nuclear chromatin, micro-nucleoli having ill-defined eosinophilic cytoplasm. Fair number of proliferating blood vessels and congested vascular channels are also seen. No evidence of granuloma or malignancy.

 

Discussion

Acute intestinal obstruction (AIO) is a surgical emergency necessitating surgical exploration and cause directed treatment. Common causes of AIO in adolescent population in India include adhesions, herniation, tuberculosis[7], intussusception, and less commonly neoplasia. Most of the times the diagnosis is clinical and the surgeon does not wait for the sophisticated radiological tests to substantiate the clinical finding. An erect abdominal X-ray is sufficient to aid in the diagnosis and head for surgical exploration. Hence a proper pre-operative diagnosis is not possible in majority of AIO. In our case also the clinical signs and symptoms were suggestive of acute bowel obstruction and she had a CT scan done at some other centre which was also consistent with the clinical diagnosis hence we proceeded for exploratory laparotomy.

 

IMT is mainly a histopathological diagnosis and is mostly regarded as a benign tumour with a very low chance of recurrence when completely excised. Though it usually occurs in young age and is gender non-specific, its presentation in old age has also been reported.[8] Some risk factors like trauma, association with Epstein Barr virus, Human Herpes -8 virus, various autoimmune processes, IgG-4 related diseases have been identified but they don’t hold a one to one causal relationship with the disease process.[9],[10] Lung is the most common site and mesentery and omentum constitute the most common site in the abdomen. Complete surgical excision of the tumour with negative margins is the best treatment till date. IMTs of small bowel, sigmoid colon and transverse colon presenting as AIO have also been reported in literature but the overall frequency is scarce.[11],[12] Owing to the rarity of this disease, standardised guidelines for management and follow up still lack in the literature.

 

Regarding the malignant potential of IMTs, it is reported to be of less than 5% and prognosis depends on the grade of tumour, metastasis and ALK gene positivity. [13]Tumours with ALK gene positivity have a good prognosis and this gene expression is seen in a fair number of IMTs.[14], [15]Crezotinib, an ALK gene (anaplastic lymphoma kinase) inhibitor is the targeted therapy drug which is approved for IMT with a fair response rate of 60-70%. It is very commonly used in lung IMT and in cases of locally aggressive lesions and metastasis.[16] There is a growing body of evidence in literature regarding the steroid therapy for IMTs of different sites like lung and maxillary sinus with a positive response through unknown mechanisms but this intervention will require consolidation and authentication via further studies.[17] Malignant gastric IMT with diffuse peritoneal and liver metastasis has also been reported in literature and hence malignant nature of IMT cannot be overlooked and even after complete excision, regular follow up of the patient with local examination and radiological imaging is mandatory.[13] Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is also a malignant and aggressive variant of IMT which carries a high metastatic potential and poor prognosis and it presents in older age with a male preponderance. On immunostaining it is differentiated from the regular IMT by perinuclear ALK gene staining and RANBP-2/ALK fusion gene arrangement as compared to cytoplasmic ALK gene staining in the later. EIMS of ileocaecal junction has also been reported in literature.[18]

 

Conclusion

Ileo-caecal junction IMT presenting as AIO is a very rare case scenario and surgical management is in accordance with the management protocol of AIO and should be guided by the general condition of the patient, overall extent of disease, feasibility of resection with or without stoma creation or anastomosis. Preoperative histopathological diagnosis should only be reserved for stable patients not requiring emergency surgery. Since malignant potential and recurrences have also been described, regular follow up is necessary. Further research and studies are required for better understanding of IMT pathogenesis and genetics for innovation of refined diagnostic tests, novel chemotherapeutic agents for targeted therapy and prediction of prognosis. Presently, complete excision of the tumour with negative margins, if possible is considered to be the standard of care.

 

Funding Sources/ Financial support: none declared

Conflicts of interest: none declared

Patient’s permission: written and informed consent taken

 

REFERENCES

  1. Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 ( 4 th) Pathology. 2014 Feb; 46 ( 2 ): 95 - 104 . doi: 10 . 1097 /PAT.0000000000000050. PMID: 24378391.
  2. Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory Myofibroblastic Tumors: Current Update. Radiol Clin North 2016 May;54(3):553-63. doi: 10.1016/j.rcl.2015.12.005. Epub 2016 Mar 12. PMID: 27153788.
  3. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008 Apr;61(4):428-37. doi: 10.1136/jcp.2007.049387. Epub 2007 Oct 15. PMID: 17938159.
  4. Werner RL, Castle JT. Inflammatory Myofibroblastic Tumor of the Nasal Cavity. Head Neck 2016 Sep;10(3):336-9. doi: 10.1007/s12105-015-0662-9. Epub 2015 Oct PMID: 26483083; PMCID: PMC4972743.
  5. Yuan C, Fan J, Xu L. Inflammatory myofibroblastic tumor of the upper arm: A case report. Medicine (Baltimore). 2023 Dec 15;102(50):e36558. doi: 10.1097/ MD.0000000000036558. PMID: 38115338; PMCID: PMC10727551.
  6. Attili SV, Chandra CR, Hemant DK, Bapsy PP, RamaRao C, Anupama G. Retroperitoneal inflammatory myofibroblastic tumor. World J Surg Oncol. 2005 Oct 8;3:66. doi: 10.1186/1477-7819-3-66. PMID: 16212671; PMCID: PMC1276822.
  7. Singh A, Sahu MK, Panigrahi M, Behera MK, UthanSingh K, Kar C, Narayan J. Abdominal tuberculosis in Indians: Still very pertinent. J Clin Tuberc Other Mycobact Dis. 2019 Mar 7;15:100097. doi: 10.1016/j.jctube.2019.100097. PMID: 31720424; PMCID: PMC6830178.
  8. Kosma L, Khaldi L, Galani P, Mytas D, Lafoyianni S. A rare case of an inflammatory myofibroblastic tumor in a middle-aged Case Rep Oncol Med. 2012;2012:148053. doi: 10.1155/2012/148053. Epub 2012 Oct 4. PMID: 23091756; PMCID: PMC3471408.
  9. Kinik B, Tural Onur S, Bicen A, Kara K, Aker C. Inflammatory myofibroblastic tumors: Diagnostic challenges and treatment strategies - A case report and literature review. Respir Med Case 2024 Sep 21;52:102117. doi: 10.1016/j.rmcr.2024.102117. PMID: 39386380; PMCID: PMC11462055.
  10. Gong S, Auer I, Duggal R, Pittaluga S, Raffeld M, Jaffe ES. Epstein-Barr virus- associated inflammatory pseudotumor presenting as a colonic mass. Hum Pathol. 2015 Dec;46(12):1956-61. doi: 10.1016/j.humpath.2015.08.011. Epub 2015 Sep 10. PMID: 26477709; PMCID: PMC4651716.
  11. Chinnakkulam Kandhasamy S, Sundaramurthi S, Vijayakumar C, Goneppanavar M, Nelamangala Ramakrishnaiah VP. Inflammatory Myofibroblastic Tumor of Sigmoid Colon: Unusual Cause of Intestinal Obstruction. Cureus. 2020 Nov 30;12(11):e11809. doi: 10.7759/cureus.11809. PMID: 33409054; PMCID: PMC7779172.
  12. Raffaeli E, Cardinali L, Fianchini M, Brancorsini D, Mosca P, Marmorale C. Inflammatory myofibroblastic tumor of the transverse colon with synchronous gastrointestinal stromal tumor in a patient with ulcerative colitis: a case report. Int J Surg Case Rep. 2019;60:141-144. doi: 10.1016/j.ijscr.2019.06.012. Epub 2019 Jun 12. PMID: 31220684; PMCID: PMC6584907.
  13. Megan Spafford, Danley Lunn, Peter Graham, Malignant inflammatory myofibroblastic tumor: a rare case presentation, Journal of Surgical Case Reports, Volume 2022, Issue 9, September 2022, rjac403, https://doi.org/10.1093/jscr/rjac403
  14. Wang Z, Zhao X, Li K, Yao W, Dong K, Xiao X, Zheng S. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center. Pediatric surgery international. 2016 Mar;32(3):239-43.
  15. Mohammad N, Haimes JD, Mishkin S, Kudlow BA, Leong MY, Chew SH, Koay E, Whitehouse A, Cope N, Ali RH, Köbel M, Stewart CJR, McCluggage WG, Lee CH. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Am J Surg Pathol. 2018 Oct;42(10):1353-1359. doi: 10.1097/ PAS.0000000000001120. PMID: 30015720.
  16. Theilen TM, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, Klingebiel T, Lehrnbecher T. Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/ pbc.26920. Epub 2017 Dec 29. PMID: 29286567.
  17. Zhu Z, Zha Y, Wang W, Wang X, Gao Y, Lv Inflammatory Myofibroblastic Tumors in Paranasal Sinus and Nasopharynx: A Clinical Retrospective Study of 13 Cases. Biomed Res Int. 2018 Oct 15;2018:7928241. doi: 10.1155/2018/7928241. PMID: 30410939; PMCID: PMC6205320.
  18. Yu L, Liu J, Lao IW, Luo Z, Wang J. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature. Diagn Pathol. 2016 Jul 27;11(1):67. doi: 1186/s13000-016-0517-z. PMID: 27460384; PMCID: PMC4962498.

 

 

 

Recommended Articles
Case Series Open Access
Colorectal Adenomas: A Case Series at a Tertiary Care Centre
2025, Volume-6, Issue-5 : 2051-2058
Original Article Open Access
A Comparative Study between Intrathecal Bupivacaine with Dexmedetomidine and Intrathecal Bupivacaine with Buprenorphine for Post-operative Analgesia in Lower Abdominal Surgery
2025, Volume-6, Issue 6 : 384-388
DOI: 10.5281/zenodo.17620939
Original Article Open Access
Correlation Between Serum Calcium, Phosphorus, And Alkaline Phosphatase Levels and the Stages of Fracture Healing
2025, Volume-6, Issue-5 : 2077-2081
Original Article Open Access
Screening of Hypertension among Outpatients at a Tertiary Care Centre in Gonda (UP), INDIA
2025, Volume-6, Issue 6 : 289-291
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
6 Views
9 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright IJMPR | All Rights Reserved